• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares (NQ:KNSA)

    78.81 +15.28 (+24.05%)
    Streaming Delayed Price Updated: 2:32 PM EDT, Jul 28, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 2,013,379
    Open 70.06
    Bid (Size) 78.72 (100)
    Ask (Size) 78.90 (200)
    Prev. Close 63.53
    Today's Range 67.35 - 81.97
    52wk Range 26.51 - 67.53
    Shares Outstanding 71,726,685
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Which stocks are gapping on Tuesday? ↗
    Via Chartmill
    News headline image
    Kiniksa Pharmaceuticals International Q2 Earnings Call Highlights ↗
    Kiniksa Pharmaceuticals International (NASDAQ:KNSA) reported second-quarter ARCALYST revenue of $243.6 million, up 55% from a year earlier and more than $29 million from the first quarter, as the... 
    Via MarketBeat
    Topics Artificial Intelligence Earnings

    Performance

    YTD
    +87.6%
    +87.6%
    1 Month
    +26.3%
    +26.3%
    3 Month
    +80.7%
    +80.7%
    6 Month
    +82.4%
    +82.4%
    1 Year
    +191.5%
    +191.5%

    More News

    Read More
    Kiniksa Pharmaceuticals (NASDAQ:KNSA) Growth Stock Surges on Revenue Beat and Raised Guidance ↗
    Via Chartmill
    Kiniksa Pharmaceuticals (NASDAQ:KNSA): A High-Growth Stock with Strong Technical Setup ↗
    Via Chartmill
    Kiniksa Pharmaceuticals (NASDAQ:KNSA): A High Growth Momentum Stock With a Breakout Setup ↗
    Via Chartmill
    Kiniksa Pharmaceuticals (NASDAQ:KNSA) Qualifies as an Affordable Growth Stock With Strong Revenue and Earnings Momentum ↗
    Via Chartmill
    Kiniksa Pharmaceuticals International Plc (NASDAQ:KNSA) Presents a Compelling GARP Opportunity ↗
    Via Chartmill
    Kiniksa Pharmaceuticals (NASDAQ:KNSA) Screens as Affordable Growth ↗
    Via Chartmill
    Kiniksa Pharmaceuticals (KNSA) Shows Explosive Potential with Perfect Minervini Trend Template and 460% EPS Growth ↗
    Via Chartmill
    Kiniksa Pharmaceuticals (NASDAQ:KNSA) Surges on Q1 Earnings Beat and Raised ARCALYST Guidance ↗
    Via Chartmill
    Topics Earnings
    News headline image
    Kiniksa (KNSA) Q1 2026 Earnings Transcript ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally ↗
    Via MarketBeat
    News headline image
    Why Kiniksa Pharmaceuticals International Stock Raced Nearly 24% Higher Today ↗
    Via The Motley Fool
    Kiniksa Pharmaceuticals (NASDAQ:KNSA) Surfaces as a GARP Opportunity with a Growth Rating of 8 ↗
    Via Chartmill
    Kiniksa Pharmaceuticals (NASDAQ:KNSA) Fits the Minervini Trend Template with High-Growth Momentum ↗
    Via Chartmill
    Kiniksa Pharmaceuticals (NASDAQ:KNSA) Presents a Compelling Growth and Technical Setup ↗
    Via Chartmill
    Kiniksa Pharmaceuticals (NASDAQ:KNSA) Presents a High-Growth Momentum Setup ↗
    Via Chartmill
    Gapping stocks in Tuesday's session ↗
    Via Chartmill
    News headline image
    What This $309K Kiniksa Insider Sale Might Signal Amid a 120% Stock Surge ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Kiniksa Pharmaceuticals (KNSA) Shows High Growth Momentum and Technical Breakout Potential ↗
    Via Chartmill
    Kiniksa Pharmaceuticals (NASDAQ:KNSA) Emerges as a Top GARP Investment ↗
    Via Chartmill
    Kiniksa Pharmaceuticals (NASDAQ:KNSA) Shows Strong Growth and Bullish Chart Setup ↗
    Via Chartmill
    Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Shows High-Growth Momentum and Strong Technical Setup ↗
    Via Chartmill
    Kiniksa Pharmaceuticals (NASDAQ:KNSA): A Prime Example of Affordable Growth (GARP) Investing ↗
    Via Chartmill
    Kiniksa Pharmaceuticals (NASDAQ:KNSA) Emerges as a Compelling Value Investment ↗
    Via Chartmill

    Frequently Asked Questions

    Is Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares publicly traded?
    Yes, Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares is publicly traded.
    What exchange does Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares trade on?
    Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares?
    The ticker symbol for Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares is KNSA on the Nasdaq Stock Market
    What is the current price of Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares?
    The current price of Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares is 78.81
    When was Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares last traded?
    The last trade of Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares was at 07/28/26 02:32 PM ET
    What is the market capitalization of Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares?
    The market capitalization of Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares is 5.65B
    How many shares of Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares are outstanding?
    Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares has 6B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.